Notice of Meeting; Moving Into the Future-New Dimensions and Strategies for Women's Health Research for the National Institutes of Health, 38449-38450 [E9-18535]
Download as PDF
Federal Register / Vol. 74, No. 147 / Monday, August 3, 2009 / Notices
their annual registration using choices
on the DRLM menu. Once you choose
to register or update your annual
registration the system will prompt you
through the entry of information about
your establishment and your devices. If
you have any problems with this
process, e-mail: reglist@cdrh.fda.gov or
call 301–796–7400 for assistance. (Note:
this e-mail address and this telephone
number are for assistance with
establishment registration only, and not
for any other aspects of medical device
user fees.) Problems with BER should be
directed to bloodregis@fda.hhs.gov or
call 301–827–3546.
D. Step Four—Enter Your DFUF Order
PIN and PCN
After completing your annual or
initial registration and device listing,
you will be prompted to enter your
DFUF order PIN and PCN, when
applicable. This process does not apply
to licensed biologic devices. CBER will
send invoices for payment of the
establishment registration fee to
companies who only manufacture
licensed biologics devices. Fees are only
required for those establishments
defined in section I of this document.
Dated: July 28, 2009.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
[FR Doc. E9–18456 Filed 7–31–09; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
sroberts on DSKD5P82C1PROD with NOTICES
Notice of Meeting; Moving Into the
Future—New Dimensions and
Strategies for Women’s Health
Research for the National Institutes of
Health
Notice is hereby given that the Office
of Research on Women’s Health
(ORWH), Office of the Director, National
Institutes of Health, Department of
Health and Human Services, in
collaboration with the Warren Alpert
Medical School of Brown University
and the Women & Infants Hospital of
Rhode Island, will convene a public
hearing and scientific workshop on
September 21–23, 2009, at the Women
& Infants Hospital of Rhode Island
Conference Center, Providence, Rhode
Island.
Purpose of the Meeting
With rapid advances in science and
wider global understanding of women’s
health and sex/gender contributions to
VerDate Nov<24>2008
16:05 Jul 31, 2009
Jkt 217001
well-being and disease, the purpose of
the meeting is to ensure that NIH
continues to support cutting-edge
women’s health research that is based
upon the most advanced techniques and
methodologies. The meeting format is
designed to promote an interactive
discussion involving leading scientists,
advocacy groups, public policy experts,
health care providers, and the general
public. The Providence meeting is the
third in a series that will be convened
throughout the Nation to help the
ORWH and NIH move into the next
decade of women’s health research.
As science and technology advance
and fields such as computational
biology demonstrate the power of
interdisciplinary research, it remain
critical for sex and gender factors to be
integrated into broad experimental
methodologies and scientific
approaches across the lifespan.
Biomedical and behavioral research are
also necessary to understand how
cultural, ethnic, and racial differences
influence the causes, diagnosis,
progression, treatment, and outcome of
disease among different populations,
including women of diverse geographic
locations and socioeconomic
backgrounds. Furthermore, health
differences among diverse populations
of women remain a critical area in need
of continued focus and attention.
The ORWH challenges all meeting
attendees to assist the NIH in defining
the women’s health research agenda of
the future by thinking beyond
traditional women’s health issues. The
ORWH and NIH ask meeting
participants to consider creative
strategies to identify areas of research
that are best poised for advancement,
identify innovative ways in which
persistent issues of health and disease
can be addressed, and explore new
horizons of scientific concepts and
investigative approaches. Attention also
needs to be paid to new areas of science
application, new technologies, and
continuing basic science investigations.
Clinical questions that are not currently
the focus of research priorities need to
be considered to ensure that women’s
health research is optimally served and
that the ORWH can continue to provide
leadership for the benefit of women’s
health, nationally and internationally.
Meeting Format
The meeting will consist of public
testimony, scientific panels, and eight
concurrent scientific working groups.
Specifically, on September 21,
individuals representing a full spectrum
of organizations interested in
biomedical and behavioral research on
women’s health issues will have an
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
38449
opportunity to provide public testimony
from 1:30 to 5:30 p.m. On September 22
and 23, plenary sessions will focus on
the intersection of health care, public
policy, and biomedical research; on
emerging issues and trends in health
care; and on research paradigms of the
future. The eight concurrent afternoon
sessions on September 22 will focus on
a range of research areas, including
Prenatal, Infancy, and Childhood Years;
Adolescent Years; Reproductive and
Middle Years; Pregnancy; Menopausal
Transition; Elderly, Frail Elderly, and
Healthy Aging; Oral Health and
Systemic Conditions; and Careers in
Dentistry, Bioengineering, and other
Non-Medical Disciplines.
On September 23 the morning session
will be devoted to reports by the
working group co-chairs regarding the
recommendations emerging from
working group deliberations on the
previous day. The meeting will adjourn
at 1:15 p.m. on September 23.
Public Testimony
The ORWH invites individuals with
an interest in research related to
women’s health to provide written and/
or oral testimony on these topics and/
or on issues related to the sustained
advancement of women in various
biomedical careers. Due to time
constraints, only one representative
from an organization or professional
specialty group may give oral testimony.
Individuals not representing an
organized entity but a personal point of
view are similarly invited to present
written and/or oral testimony. A letter
of intent to present oral testimony is
necessary and should be sent
electronically to https://
www.orwhmeetings.com/
movingintothefuture/ or by mail to Ms.
Jory Barone, Educational Services, Inc.,
4350 East-West Highway, Suite 1100,
Bethesda, MD 20814, no later than
September 13, 2009. The date of receipt
of the communication will establish the
order of those selected to give oral
testimony at the September meeting.
Those wishing to present oral
testimony are also asked to submit a
written form of their testimony that is
limited to a maximum of 10 pages,
double spaced, 12-point font, and
should include a brief description of
their organization. Electronic
submission to the above Web site is
preferred; however, for those who do
not have access to electronic means,
written testimony, bound by the
restrictions previously noted and
postmarked no later than September 13,
2009, can be mailed to Ms. Jory Barone
at the above address. All written
presentations must meet the established
E:\FR\FM\03AUN1.SGM
03AUN1
38450
Federal Register / Vol. 74, No. 147 / Monday, August 3, 2009 / Notices
page limitations. Submissions exceeding
this limit will not be accepted and will
be returned. Oral testimony of this
material at the meeting will be limited
to no more than 5–6 minutes in length.
Because of time constraints for oral
testimony, testifiers may not be able to
present the complete information as it is
contained in their written form
submitted for inclusion in the public
record for the meeting. Therefore,
testifiers are requested to summarize the
major points of emphasis from the
written testimony, not to exceed 6
minutes of oral testimony. Those
individuals or organizations that have
indicated they will present oral
testimony at the meeting in Providence
will be notified prior to the meeting
regarding the approximate time for their
oral presentation.
Individuals and organizations wishing
to provide written statements only
should send a copy of their statements,
electronically or by mail, to the above
Web site or address by September 13,
2009. Written testimony received by
that date will be made available at the
September 21–23 meeting. Logistics
questions related to this meeting should
be addressed to Ms. Jory Barone at ESI,
while program-specific questions
should be addressed to Ms. Maureen
Pearlman at the Warren Alpert Medical
School of Brown University,
Providence, Rhode Island, 401–276–
7800, ext. 123, mpearlman@wihri.org.
At the conclusion of the regional
meetings, the ORWH will hold a
meeting at the NIH to summarize the
deliberations from the regional
conferences. The resulting report to the
ORWH and the NIH will ensure that
women’s health research in the coming
decade continues to support a vigorous
research agenda incorporating the latest
advances in technology and cuttingedge science.
Dated: July 28, 2009.
Raynard S. Kington,
Acting Director, National Institutes of Health.
[FR Doc. E9–18535 Filed 7–31–09; 8:45 am]
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: President’s Cancer
Panel.
Date: September 22, 2009.
Time: 8 a.m. to 4:10 p.m.
Agenda: America’s Demographic and
Cultural Transformation: Implications for the
Cancer Enterprise.
Place: The Westin Seattle, 1900 Fifth
Avenue, Seattle, WA 98101.
Contact Person: Abby B. Sandler, PhD,
Executive Secretary, Chief, Institute Review
Office, Office of the Director, 6116 Executive
Blvd., Suite 220, MSC 8349, National Cancer
Institute, NIH, Bethesda, MD 20892–8349.
(301) 451–9399. sandlera@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page:
deainfo.nci.nih.gov/advisory/pcp/pcp.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: July 28, 2009.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–18531 Filed 7–31–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
sroberts on DSKD5P82C1PROD with NOTICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
President’s Cancer Panel.
VerDate Nov<24>2008
16:05 Jul 31, 2009
Jkt 217001
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Council for
Biomedical Imaging and Bioengineering.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council for Biomedical Imaging and
Bioengineering. NACBIB, September 2009.
Date: September 11, 2009.
Open: 9 a.m. to 1 p.m.
Agenda: Report from the Institute Director,
other Institute Staff and presentations of
working group reports.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Closed: 1 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Anthony Demsey, PhD,
Director, National Institute of Biomedical
Imaging, and Bioengineering, 6701
Democracy Boulevard, Room 241, Bethesda,
MD 20892.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.nibib1.nih.gov/about/NACBIB/
NACBIB.htm, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.701, ARRA Related
Biomedical Research and Research Support
Awards. National Institutes of Health, HHS)
Dated: July 28, 2009.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–18529 Filed 7–31–09; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\03AUN1.SGM
03AUN1
Agencies
[Federal Register Volume 74, Number 147 (Monday, August 3, 2009)]
[Notices]
[Pages 38449-38450]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-18535]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Notice of Meeting; Moving Into the Future--New Dimensions and
Strategies for Women's Health Research for the National Institutes of
Health
Notice is hereby given that the Office of Research on Women's
Health (ORWH), Office of the Director, National Institutes of Health,
Department of Health and Human Services, in collaboration with the
Warren Alpert Medical School of Brown University and the Women &
Infants Hospital of Rhode Island, will convene a public hearing and
scientific workshop on September 21-23, 2009, at the Women & Infants
Hospital of Rhode Island Conference Center, Providence, Rhode Island.
Purpose of the Meeting
With rapid advances in science and wider global understanding of
women's health and sex/gender contributions to well-being and disease,
the purpose of the meeting is to ensure that NIH continues to support
cutting-edge women's health research that is based upon the most
advanced techniques and methodologies. The meeting format is designed
to promote an interactive discussion involving leading scientists,
advocacy groups, public policy experts, health care providers, and the
general public. The Providence meeting is the third in a series that
will be convened throughout the Nation to help the ORWH and NIH move
into the next decade of women's health research.
As science and technology advance and fields such as computational
biology demonstrate the power of interdisciplinary research, it remain
critical for sex and gender factors to be integrated into broad
experimental methodologies and scientific approaches across the
lifespan. Biomedical and behavioral research are also necessary to
understand how cultural, ethnic, and racial differences influence the
causes, diagnosis, progression, treatment, and outcome of disease among
different populations, including women of diverse geographic locations
and socioeconomic backgrounds. Furthermore, health differences among
diverse populations of women remain a critical area in need of
continued focus and attention.
The ORWH challenges all meeting attendees to assist the NIH in
defining the women's health research agenda of the future by thinking
beyond traditional women's health issues. The ORWH and NIH ask meeting
participants to consider creative strategies to identify areas of
research that are best poised for advancement, identify innovative ways
in which persistent issues of health and disease can be addressed, and
explore new horizons of scientific concepts and investigative
approaches. Attention also needs to be paid to new areas of science
application, new technologies, and continuing basic science
investigations. Clinical questions that are not currently the focus of
research priorities need to be considered to ensure that women's health
research is optimally served and that the ORWH can continue to provide
leadership for the benefit of women's health, nationally and
internationally.
Meeting Format
The meeting will consist of public testimony, scientific panels,
and eight concurrent scientific working groups. Specifically, on
September 21, individuals representing a full spectrum of organizations
interested in biomedical and behavioral research on women's health
issues will have an opportunity to provide public testimony from 1:30
to 5:30 p.m. On September 22 and 23, plenary sessions will focus on the
intersection of health care, public policy, and biomedical research; on
emerging issues and trends in health care; and on research paradigms of
the future. The eight concurrent afternoon sessions on September 22
will focus on a range of research areas, including Prenatal, Infancy,
and Childhood Years; Adolescent Years; Reproductive and Middle Years;
Pregnancy; Menopausal Transition; Elderly, Frail Elderly, and Healthy
Aging; Oral Health and Systemic Conditions; and Careers in Dentistry,
Bioengineering, and other Non-Medical Disciplines.
On September 23 the morning session will be devoted to reports by
the working group co-chairs regarding the recommendations emerging from
working group deliberations on the previous day. The meeting will
adjourn at 1:15 p.m. on September 23.
Public Testimony
The ORWH invites individuals with an interest in research related
to women's health to provide written and/or oral testimony on these
topics and/or on issues related to the sustained advancement of women
in various biomedical careers. Due to time constraints, only one
representative from an organization or professional specialty group may
give oral testimony. Individuals not representing an organized entity
but a personal point of view are similarly invited to present written
and/or oral testimony. A letter of intent to present oral testimony is
necessary and should be sent electronically to https://www.orwhmeetings.com/movingintothefuture/ or by mail to Ms. Jory
Barone, Educational Services, Inc., 4350 East-West Highway, Suite 1100,
Bethesda, MD 20814, no later than September 13, 2009. The date of
receipt of the communication will establish the order of those selected
to give oral testimony at the September meeting.
Those wishing to present oral testimony are also asked to submit a
written form of their testimony that is limited to a maximum of 10
pages, double spaced, 12-point font, and should include a brief
description of their organization. Electronic submission to the above
Web site is preferred; however, for those who do not have access to
electronic means, written testimony, bound by the restrictions
previously noted and postmarked no later than September 13, 2009, can
be mailed to Ms. Jory Barone at the above address. All written
presentations must meet the established
[[Page 38450]]
page limitations. Submissions exceeding this limit will not be accepted
and will be returned. Oral testimony of this material at the meeting
will be limited to no more than 5-6 minutes in length.
Because of time constraints for oral testimony, testifiers may not
be able to present the complete information as it is contained in their
written form submitted for inclusion in the public record for the
meeting. Therefore, testifiers are requested to summarize the major
points of emphasis from the written testimony, not to exceed 6 minutes
of oral testimony. Those individuals or organizations that have
indicated they will present oral testimony at the meeting in Providence
will be notified prior to the meeting regarding the approximate time
for their oral presentation.
Individuals and organizations wishing to provide written statements
only should send a copy of their statements, electronically or by mail,
to the above Web site or address by September 13, 2009. Written
testimony received by that date will be made available at the September
21-23 meeting. Logistics questions related to this meeting should be
addressed to Ms. Jory Barone at ESI, while program-specific questions
should be addressed to Ms. Maureen Pearlman at the Warren Alpert
Medical School of Brown University, Providence, Rhode Island, 401-276-
7800, ext. 123, mpearlman@wihri.org.
At the conclusion of the regional meetings, the ORWH will hold a
meeting at the NIH to summarize the deliberations from the regional
conferences. The resulting report to the ORWH and the NIH will ensure
that women's health research in the coming decade continues to support
a vigorous research agenda incorporating the latest advances in
technology and cutting-edge science.
Dated: July 28, 2009.
Raynard S. Kington,
Acting Director, National Institutes of Health.
[FR Doc. E9-18535 Filed 7-31-09; 8:45 am]
BILLING CODE 4140-01-P